Page last updated: 2024-08-18

arginine vasopressin and relcovaptan

arginine vasopressin has been researched along with relcovaptan in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	31 (64.58)	18.2507
2000's	10 (20.83)	29.6817
2010's	7 (14.58)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Auzan, C; Berti-Mattera, L; Clauser, E; Madhun, Z; Thibonnier, M; Wilkins, P	1
Berti-Mattera, LN; Dulin, N; Mattera, R; Preston, JA; Thibonnier, M; Wilkins, PL	1
Barberis, C; Carnazzi, E; Cotte, N; Jard, S; Mahe, E; Mouillac, B; Phalipou, S; Seyer, R	1
Ishii, N; Kusayama, T; Saito, M; Sugimoto, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T	1
Akerlund, M; Bossmar, T; Brouard, R; Kostrzewska, A; Laudanski, T; Lemancewicz, A; Serradeil-Le Gal, C; Steinwall, M	1
Aumelas, A; Balestre, MN; Barberis, C; Cotte, N; Durroux, T; Hibert, M; Mahé, E; Manning, M; Morin, D; Mouillac, B; Phalipou, S	1
Double-Cazanave, E; Garcia, C; Guillon, G; Maffrand, JP; Pascal, M; Raufaste, D; Serradeil-Le Gal, C	1
Arban, R; Curcuruto, O; Dickinson, BA; Green, A; Griffante, C; Haslam, CP	1
Albizu, L; Ansanay, H; Bazin, H; Durroux, T; Manning, M; Mouillac, B; Seyer, R; Teppaz, G	1
Boutin, M; Le Fur, G; Maffrand, JP; Serradeil-Le Gal, C; Villanova, G	1
Delisee, C; Dol, F; Garcia, C; Herbert, JM; Le Fur, G; Maffrand, JP; Marty, E; Raufaste, D; Schaeffer, P; Serradeil-Le Gal, C	1
Garcia, C; Le Fur, G; Maffrand, JP; Marty, E; Raufaste, D; Serradeil-Le Gal, C	2
Bourrié, B; Carayon, P; Casellas, P; Garcia, C; Le Fur, G; Maffrand, JP; Raufaste, D; Serradeil-Le Gal, C	1
Christophe, B; Garcia, C; Guiraudou, P; Lacour, C; Le Fur, G; Maffrand, JP; Nisato, D; Serradeil-Le Gal, C; Villanova, G; Wagnon, J	1
Burrell, LM; Buxton, BB; Chen, JR; Johnston, CI; Liu, JJ	1
Bax, WA; Bos, E; Nisato, D; Saxena, PR; Stam, WB; Van der Graaf, PH	1
Goncharevskaya, OA; Natochin, YV; Shakhmatova, EI	1
Akerlund, M; Bossmar, T; Rasmussen, T	1
Barthelmebs, M; Grima, M; Imbs, JL; Krieger, JP; Nisato, D	1
Calò, G; Regoli, D; Rizzi, A; Traina, L	1
Brouard, R; Brunner, HR; Burnier, M; Gerc, V; Hayoz, D; Lahmy, JP; Pechère-Bertschi, A; Weber, R	1
Ishikawa, S; Saito, T	1
Akerlund, M; Bossmar, T; Kostrzewska, A; Laudanski, T; Serradeil-Le Gal, C; Steinwall, M	1
Koshio, H; Matsuhisa, A; Sakamoto, K; Tanaka, A; Taniguchi, N; Yatsu, T	1
Saxena, PR; Stam, WB; Van der Graaf, PH	1
Heinemann, A; Holzer, P; Horina, G; Pertl, C; Peskar, BA; Stauber, RE	1
Brouard, R; Donat, F; Dreux, F; Fournie, D; Jang, H; Laporte, V; Lockwood, G; Pignol, R; Serradeil Le Gal, C	1
Dayanithi, G; Gouzénes, L; Moos, FC; Richard, P; Sabatier, N	1
Andres, M; Boccara, G; Breton, C; Colson, P; Derick, S; Grazzini, E; Guérineau, NC; Guillon, G; Raufaste, D; Rickwaert, F; Serradeil-le Gal, C	1
Ayajiki, K; Fujioka, H; Okamura, T; Toda, N	1
Chen, YL; Lai, FM; Shepherd, C; Spinelli, W	1
Dayanithi, G; Gouzènes, L; Moos, FC	1
Cros, G; Laurent, F; Méchaly, I; Portet, K; Serrano, J	1
Brouard, R; DiBlasi, TP; Kilani, A; Leenhardt, AF; Rahman, M; Smith, MC; Thibonnier, M; Warner, K	1
Lankhuizen, IM; Saxena, PR; Schoemaker, RG; van Veghel, R	1
Ishii, N; Kusayama, T; Tahara, A; Tanaka, A; Taniguchi, N; Tomura, Y; Tsukada, J; Uchida, W; Yatsu, T	1
Dapzol, J; Girod, V; Grélot, L; Maffrand, JP; Serradeil-Le Gal, C	1
Chevaleyre, V; Desarménien, MG; Moos, FC	1
Ji, X; Kurahashi, K; Murakami, S; Nishihashi, T; Trandafir, CC; Wang, A	1
Streefkerk, JO; van Zwieten, PA	1
Bankhead, P; Curtis, TM; Jeffries, O; Lozano, MM; McGahon, MK; McGeown, JG; Scholfield, CN	1
Kamo, I; Kuno, M; Shintani, Y; Ueno, H	1
Arban, R; Griffante, C; Perdonà, E	1
Barr, LA; Carter, RL; Cheung, JY; Coleman, RC; Feldman, AM; Gao, E; Grisanti, LA; Houser, SR; Koch, WJ; Li, X; Makarewich, CA; Myers, VD; Song, J; Tilley, DG; Troupes, CD; Yu, D; Zhu, W	1
Aman, NA; Hancock, M; Kang, SW; Kuenzel, WJ; Nagarajan, G	1
Dehpour, AR; Doustimotlagh, AH; Javadi-Paydar, M; Javadian, N; Rahimi, N	1
Best, C; Brydges, NM; Drake, AJ; Hall, J; Lewis, C; Rule, L; Thomas, KL; Watkin, H	1

Reviews

2 review(s) available for arginine vasopressin and relcovaptan

Article	Year
[Disorders of body water regulation and the therapy--vasopressin antagonists]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997, Sep-10, Volume: 86, Issue:9 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Indoles; Liver Cirrhosis, Experimental; Pyrrolidines	1997
Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents. Autonomic & autacoid pharmacology, 2006, Volume: 26, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Drug Design; Heart Failure; Hormone Antagonists; Humans; Hypertension; Inappropriate ADH Syndrome; Indoles; Presynaptic Terminals; Pyrrolidines; Receptors, Vasopressin; Renal Artery; Sympathetic Nervous System; Synaptic Transmission; Tolvaptan; Vasoconstriction; Vasoconstrictor Agents	2006

Article

Year

[Disorders of body water regulation and the therapy--vasopressin antagonists].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997, Sep-10, Volume: 86, Issue:9

Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Indoles; Liver Cirrhosis, Experimental; Pyrrolidines

1997

Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.

Autonomic & autacoid pharmacology, 2006, Volume: 26, Issue:2

Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Drug Design; Heart Failure; Hormone Antagonists; Humans; Hypertension; Inappropriate ADH Syndrome; Indoles; Presynaptic Terminals; Pyrrolidines; Receptors, Vasopressin; Renal Artery; Sympathetic Nervous System; Synaptic Transmission; Tolvaptan; Vasoconstriction; Vasoconstrictor Agents

2006

Trials

3 trial(s) available for arginine vasopressin and relcovaptan

Article	Year
Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 30, Issue:5 Topics: Administration, Oral; Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcitonin Gene-Related Peptide; Double-Blind Method; Forearm; Hormone Antagonists; Humans; Indoles; Injections, Intra-Arterial; Injections, Intradermal; Male; Pyrrolidines; Radial Artery; Reference Values; Regional Blood Flow; Skin; Vasoconstriction	1997
Safety, tolerability, and pharmacokinetics of SR 49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteers. Advances in experimental medicine and biology, 1998, Volume: 449 Topics: Administration, Oral; Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Platelets; Blood Pressure; Diuresis; Dose-Response Relationship, Drug; Double-Blind Method; Hormone Antagonists; Humans; Indoles; Male; Metabolic Clearance Rate; Placebos; Platelet Aggregation Inhibitors; Pyrrolidines; Regional Blood Flow; Skin; Vasopressins	1998
Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:6 Topics: Administration, Oral; Adult; Aldosterone; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Black People; Blood Volume; Cross-Over Studies; Double-Blind Method; Heart Rate; Hormone Antagonists; Humans; Hypertension; Indoles; Kidney Function Tests; Male; Platelet Aggregation; Pyrrolidines; Renin; Serum Albumin; Sodium; Treatment Outcome; White People	1999

Other Studies

43 other study(ies) available for arginine vasopressin and relcovaptan

Article	Year
Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. The Journal of biological chemistry, 1994, Feb-04, Volume: 269, Issue:5 Topics: Amino Acid Sequence; Animals; Arginine Vasopressin; Base Sequence; Binding, Competitive; Cell Line; CHO Cells; Cloning, Molecular; Cricetinae; DNA Probes; DNA, Complementary; Gene Expression; Humans; Inositol Phosphates; Kinetics; Liver; Molecular Sequence Data; Oligodeoxyribonucleotides; Pertussis Toxin; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Recombinant Proteins; Sequence Homology, Amino Acid; Transfection; Virulence Factors, Bordetella	1994
The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways. Endocrinology, 1997, Volume: 138, Issue:10 Topics: Animals; Arachidonic Acid; Base Sequence; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; CHO Cells; Cricetinae; Cyclic AMP; DNA; Dose-Response Relationship, Drug; Female; Humans; Ligands; Pertussis Toxin; Phenotype; Phosphorylation; Pituitary Gland; Protein Binding; Protein Kinase C; Receptors, Vasopressin; Signal Transduction; Thymidine; Tritium; Type C Phospholipases; Virulence Factors, Bordetella	1997
Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonist. The Journal of biological chemistry, 1997, Oct-17, Volume: 272, Issue:42 Topics: Amino Acid Sequence; Animals; CHO Cells; Cricetinae; Endopeptidases; Glycosylation; Humans; Hydrolysis; Molecular Sequence Data; Mutagenesis, Site-Directed; Peptide Mapping; Peptides; Photoaffinity Labels; Precipitin Tests; Protein Binding; Receptors, Vasopressin; Recombinant Proteins	1997
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells. British journal of pharmacology, 1998, Volume: 125, Issue:7 Topics: Animals; Benzazepines; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Humans; Indoles; Morpholines; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Spiro Compounds; Transfection; Tritium	1998
Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women. British journal of obstetrics and gynaecology, 1999, Volume: 106, Issue:10 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Cell Line; Cesarean Section; Female; Hormone Antagonists; Humans; Indoles; Morpholines; Myometrium; Obstetric Labor, Premature; Oxytocin; Pregnancy; Pyrrolidines; Receptors, Oxytocin; Spiro Compounds; Vasopressins	1999
Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding. European journal of biochemistry, 2000, Volume: 267, Issue:13 Topics: Amino Acid Sequence; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding Sites; Cell Membrane; Conserved Sequence; COS Cells; Humans; Ligands; Molecular Sequence Data; Mutagenesis, Site-Directed; Receptors, Vasopressin	2000
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463. Kidney international, 2000, Volume: 58, Issue:4 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding, Competitive; Cattle; CHO Cells; Cricetinae; Dogs; Haplorhini; Homeostasis; Humans; Kidney; Kinetics; Morpholines; Rabbits; Radioligand Assay; Rats; Spiro Compounds; Swine; Tritium; Vasopressins; Water-Electrolyte Balance	2000
Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist. British journal of pharmacology, 2005, Volume: 146, Issue:5 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium; CHO Cells; Cricetinae; Humans; Indoles; Pyrrolidines; Receptors, Oxytocin	2005
Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands. Journal of medicinal chemistry, 2007, Oct-04, Volume: 50, Issue:20 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Binding, Competitive; Chlorocebus aethiops; CHO Cells; COS Cells; Cricetinae; Cricetulus; Cyclic AMP; Fluoresceins; Fluorescence Polarization; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Ligands; Oligopeptides; Organometallic Compounds; Peptides, Cyclic; Quinolinium Compounds; Radioligand Assay; Receptors, Oxytocin; Receptors, Vasopressin	2007
Effects of SR 49059, a non-peptide antagonist of vasopressin V1a receptors, on vasopressin-induced coronary vasoconstriction in conscious rabbits. Fundamental & clinical pharmacology, 1995, Volume: 9, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Coronary Vessels; Electrocardiography; Indoles; Male; Pyrrolidines; Rabbits; Stereoisomerism; Vasoconstriction	1995
Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells. The American journal of physiology, 1995, Volume: 268, Issue:1 Pt 2 Topics: Aorta; Arginine Vasopressin; Calcium; Cell Division; Cell Membrane; Cells, Cultured; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Indoles; Iodine Radioisotopes; Kinetics; Muscle, Smooth, Vascular; Oxytocin; Piperidines; Pyrrolidines; Quinolones; Radioligand Assay; Receptors, Vasopressin; Vasopressins	1995
Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes. Biochemical and biophysical research communications, 1994, Feb-28, Volume: 199, Issue:1 Topics: Animals; Arginine Vasopressin; Binding, Competitive; Cell Membrane; Humans; Indoles; Kinetics; Liver; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin	1994
Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells. Biochemical pharmacology, 1994, Feb-11, Volume: 47, Issue:4 Topics: 3T3 Cells; Animals; Arginine Vasopressin; Binding Sites; Cell Division; DNA; Flow Cytometry; Indoles; Mice; Mitogens; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin	1994
Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors. The Journal of clinical investigation, 1993, Volume: 92, Issue:1 Topics: Animals; Arginine Vasopressin; Cattle; Cell Membrane; Humans; In Vitro Techniques; Indoles; Muscle Contraction; Piperidines; Platelet Aggregation; Pyrrolidines; Quinolones; Rats; Receptors, Vasopressin	1993
Potent inhibitory effect of SR 49059, an orally active non-peptide vasopressin VIa receptor antagonist, on human arterial coronary bypass graft. Clinical science (London, England : 1979), 1995, Volume: 89, Issue:5 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arteries; Hormone Antagonists; Humans; Indoles; Mammary Arteries; Muscle Contraction; Pyrrolidines	1995
[Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists. European journal of pharmacology, 1995, Oct-16, Volume: 285, Issue:2 Topics: Adolescent; Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Child; Coronary Vessels; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Indoles; Male; Middle Aged; Muscle, Smooth, Vascular; Piperidines; Potassium; Pyrrolidines; Quinolones; Vasoconstrictor Agents	1995
Modulation of the effect of arginine-vasopressin on water and ion transport in the newt early distal tubule and frog urinary bladder by V1-antagonists. Pflugers Archiv : European journal of physiology, 1995, Volume: 430, Issue:6 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Biological Transport; Hormone Antagonists; Indoles; Ions; Kidney Tubules, Distal; Naphthalenes; Osmolar Concentration; Permeability; Protein Kinase C; Pyrrolidines; Salamandridae; Urinary Bladder; Water	1995
Effect of the non-peptide, vasopressin V1a receptor antagonist, SR 49059 and its enantiomer, SR 49770, on isolated human myometrium. Acta obstetricia et gynecologica Scandinavica, 1996, Volume: 75, Issue:6 Topics: Arginine Vasopressin; Dysmenorrhea; Female; Hormone Antagonists; Humans; In Vitro Techniques; Indoles; Myometrium; Pyrrolidines; Vasoconstrictor Agents	1996
Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059. Kidney international, 1996, Volume: 50, Issue:2 Topics: Animals; Arginine Vasopressin; Autoradiography; Hormone Antagonists; Humans; Indoles; Kidney; Kinetics; Liver; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Tissue Distribution; Tritium	1996
Vascular effects of [Arg8]vasopressin in the isolated perfused rat kidney. European journal of pharmacology, 1996, Oct-31, Volume: 314, Issue:3 Topics: Angiotensin II; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Enzyme Inhibitors; Hormone Antagonists; In Vitro Techniques; Indoles; Kidney; Male; Nitric Oxide; Norepinephrine; Perfusion; Prostaglandins; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Renal Agents; Vasoconstrictor Agents	1996
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery. Life sciences, 1997, Volume: 60, Issue:4-5 Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arteries; Benzazepines; Humans; In Vitro Techniques; Indoles; Middle Aged; Muscle, Smooth, Vascular; Oxytocin; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Stomach; Vasoconstrictor Agents	1997
Effects of the vasopressin V1a receptor antagonist, SR 49059, on the response of human uterine arteries to vasopressin and other vasoactive substances. Acta obstetricia et gynecologica Scandinavica, 1998, Volume: 77, Issue:1 Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arteries; Dinoprost; Dose-Response Relationship, Drug; Endothelin-1; Female; Humans; In Vitro Techniques; Indoles; Middle Aged; Norepinephrine; Pyrrolidines; Uterus; Vasoconstriction; Vasoconstrictor Agents	1998
Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-carbonyl) benzanilide derivatives. Chemical & pharmaceutical bulletin, 1998, Volume: 46, Issue:10 Topics: Anilides; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Biological Availability; Female; In Vitro Techniques; Indoles; Magnetic Resonance Spectroscopy; Pyrrolidines; Rabbits; Rats; Receptors, Oxytocin	1998
Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin. British journal of pharmacology, 1998, Volume: 125, Issue:4 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aorta; Arginine Vasopressin; Dose-Response Relationship, Drug; Hormone Antagonists; In Vitro Techniques; Indoles; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Piperidines; Pyrrolidines; Quinolones; Rats; Rats, Wistar; Receptors, Oxytocin; Receptors, Vasopressin; Vasotocin	1998
Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed. British journal of pharmacology, 1998, Volume: 125, Issue:6 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Drug Synergism; Hormone Antagonists; Indoles; Male; Mesenteric Arteries; Methoxamine; Perfusion; Pressoreceptors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Vasoconstriction; Vasoconstrictor Agents	1998
V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones. The Journal of physiology, 1999, Jun-15, Volume: 517 ( Pt 3) Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium; Deamino Arginine Vasopressin; In Vitro Techniques; Indoles; Kinetics; Male; Morpholines; Neurons; Pyrrolidines; Rats; Rats, Wistar; Receptors, Vasopressin; Spiro Compounds; Supraoptic Nucleus; Transcription, Genetic; Vasoconstrictor Agents; Vasopressins	1999
Vasopressin receptors in human adrenal medulla and pheochromocytoma. The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:6 Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Adult; Arginine Vasopressin; Autoradiography; Calcium; Cell Membrane; Cells, Cultured; Exocytosis; Hormone Antagonists; Humans; Indoles; Middle Aged; Pheochromocytoma; Pyrrolidines; Receptors, Vasopressin; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured	1999
Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries. Journal of hypertension, 1999, Volume: 17, Issue:5 Topics: Animals; Arginine; Arginine Vasopressin; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; In Vitro Techniques; Indoles; Macaca; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrrolidines; Receptors, Vasopressin; Vasodilation	1999
Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors. European journal of pharmacology, 1999, Jul-02, Volume: 376, Issue:1-2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arteries; Drug Antagonism; Female; Hormone Antagonists; In Vitro Techniques; Indoles; Male; Muscle, Smooth, Vascular; Oxytocin; Pyrrolidines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Uterine Contraction; Uterus; Vascular Resistance; Vasoconstriction; Vasotocin	1999
Vasopressin(4-9) fragment activates V1a-type vasopressin receptor in rat supraoptic neurones. Neuroreport, 1999, Jun-03, Volume: 10, Issue:8 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium; Fluorescent Dyes; Fura-2; Hormone Antagonists; In Vitro Techniques; Indoles; Male; Morpholines; Neurons; Peptide Fragments; Pyrrolidines; Rats; Rats, Wistar; Receptors, Vasopressin; Spiro Compounds; Supraoptic Nucleus	1999
Vasopressin V2 (SR121463A) and V1a (SR49059) receptor antagonists both inhibit desmopressin vasorelaxing activity. European journal of pharmacology, 1999, Nov-03, Volume: 383, Issue:3 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aorta; Arginine Vasopressin; Deamino Arginine Vasopressin; Endothelium, Vascular; Hemostatics; Hormone Antagonists; Indoles; Male; Morpholines; Pyrrolidines; Rats; Rats, Wistar; Spiro Compounds	1999
[Arg8]-vasopressin-induced responses on coronary and mesenteric arteries of rats with myocardial infarction: the effects of V1a- and V2-receptor antagonists. Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Coronary Circulation; Coronary Vessels; Indoles; Ligation; Male; Mesenteric Arteries; Myocardial Infarction; Pyrrolidines; Rats; Rats, Wistar; Receptors, Vasopressin; Vasoconstrictor Agents	2000
Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells. British journal of pharmacology, 2001, Volume: 133, Issue:5 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Binding, Competitive; Calcium; Cell Membrane; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Female; Humans; Indoles; Morpholines; Muscle, Smooth; Oxytocin; Piperidines; Pyrrolidines; Radioligand Assay; Receptors, Oxytocin; Receptors, Vasopressin; Spiro Compounds; Tritium; Uterus	2001
A nonpeptide vasopressin V(1a) receptor antagonist, SR 49059, does not prevent cisplatin-induced emesis in piglets. Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:3 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antiemetics; Antineoplastic Agents; Arginine Vasopressin; Cell Membrane; Cisplatin; Disease Models, Animal; Hormone Antagonists; Hypertension; Indoles; Liver; Pyrrolidines; Swine; Vomiting	2001
Interplay between presynaptic and postsynaptic activities is required for dendritic plasticity and synaptogenesis in the supraoptic nucleus. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Jan-01, Volume: 22, Issue:1 Topics: Animals; Arginine Vasopressin; Calcium; Dendrites; Excitatory Amino Acid Antagonists; Fluorescent Dyes; Hormone Antagonists; In Vitro Techniques; Indoles; Microinjections; Morpholines; N-Methylaspartate; Neuronal Plasticity; Neurons; Oxytocin; Presynaptic Terminals; Pyrrolidines; Rats; Receptors, N-Methyl-D-Aspartate; Spiro Compounds; Supraoptic Nucleus; Synapses; Synaptic Transmission	2002
Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage. Clinical and experimental pharmacology & physiology, 2004, Volume: 31, Issue:4 Topics: Animals; Arginine Vasopressin; Basilar Artery; Disease Models, Animal; Female; Indoles; Pyrans; Pyrrolidines; Quinolones; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Vasospasm, Intracranial	2004
cAMP/PKA-dependent increases in Ca Sparks, oscillations and SR Ca stores in retinal arteriolar myocytes after exposure to vasopressin. Investigative ophthalmology & visual science, 2010, Volume: 51, Issue:3 Topics: Aniline Compounds; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arterioles; Caffeine; Calcium; Calcium Signaling; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Fluorometry; Fura-2; Indoles; Microscopy, Confocal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pyrrolidines; Receptors, Vasopressin; Retinal Artery; Sarcoplasmic Reticulum; Swine; Vasoconstrictor Agents; Xanthenes	2010
Role of vasopressin V(₁A) receptor in the urethral closure reflex in rats. American journal of physiology. Renal physiology, 2011, Volume: 300, Issue:4 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Dose-Response Relationship, Drug; Female; Hormone Antagonists; In Situ Hybridization; Indoles; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Reflex; Reverse Transcriptase Polymerase Chain Reaction; Urethra	2011
Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells. European journal of pharmacology, 2012, Mar-15, Volume: 679, Issue:1-3 Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium; Cells, Cultured; Cyclic AMP; Drug Interactions; Female; Indoles; Oxytocin; Pituitary Gland, Anterior; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Time Factors; Vasotocin	2012
β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling. Circulation, 2014, Nov-11, Volume: 130, Issue:20 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium Signaling; Cardiomyopathy, Hypertrophic; Cats; Cell Line, Tumor; Colforsin; Cyclic AMP; G-Protein-Coupled Receptor Kinases; Genes, Reporter; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; HEK293 Cells; Humans; Indoles; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis, Site-Directed; Myocardial Contraction; Pyrrolidines; Receptors, Adrenergic, beta; Receptors, Vasopressin; Recombinant Fusion Proteins; Rolipram; Second Messenger Systems	2014
Central effect of vasotocin 4 receptor (VT4R/V1aR) antagonists on the stress response and food intake in chicks given neuropeptide Y (NPY). Neuroscience letters, 2016, 05-04, Volume: 620 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Chickens; Corticosterone; Eating; Immobilization; Indoles; Injections, Intraventricular; Male; Neuropeptide Y; Pyrrolidines; Receptors, Vasopressin; Stress, Psychological	2016
The modulatory effect of nitric oxide in pro- and anti-convulsive effects of vasopressin in PTZ-induced seizures threshold in mice. Epilepsy research, 2016, Volume: 126 Topics: Animals; Anticonvulsants; Antidiuretic Hormone Receptor Antagonists; Arginine; Arginine Vasopressin; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Indoles; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pentylenetetrazole; Pyrrolidines; Receptors, Vasopressin; Seizures	2016
Childhood stress impairs social function through AVP-dependent mechanisms. Translational psychiatry, 2019, 12-09, Volume: 9, Issue:1 Topics: Adult; Adverse Childhood Experiences; Aged; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Behavior, Animal; Borderline Personality Disorder; Disease Models, Animal; Female; Humans; Indoles; Male; Middle Aged; Neurophysins; Paraventricular Hypothalamic Nucleus; Protein Precursors; Pyrrolidines; Rats; Sexual Maturation; Social Behavior; Stress, Psychological; Supraoptic Nucleus; Vasopressins; Young Adult	2019